ZBIO
Zenas BioPharma·NASDAQ
--
--(--)
--
--(--)
5.32 / 10
Netural
Technically, ZBIO scores 5.32/10 with a neutral rating. The pattern of Long Lower Shadow (bullish bias) is counterbalanced by Long Upper Shadow (neutral/bearish), indicating market indecision. Recent candlestick signals are mixed, and the overall trend lacks conviction, suggesting the stock is range-bound with no clear directional momentum.
Analysis Checks(1/2)
Long Lower Shadow
Score6.95/10
Win Rate56.76%
Hist. Signals74
Avg Return1.88%
Score6.95/10
Win Rate56.76%
Hist. Signals74
Avg Return1.88%
Long Upper Shadow
Score3.69/10
Win Rate49.25%
Hist. Signals67
Avg Return1.60%
Score3.69/10
Win Rate49.25%
Hist. Signals67
Avg Return1.60%
Long Lower Shadow
Score6.95/10
Win Rate56.76%
Hist. Signals74
Avg Return1.88%
Score6.95/10
Win Rate56.76%
Hist. Signals74
Avg Return1.88%
Long Upper Shadow
Score3.69/10
Win Rate49.25%
Hist. Signals67
Avg Return1.60%
Score3.69/10
Win Rate49.25%
Hist. Signals67
Avg Return1.60%
Technical Analysis of ZBIO?
- ZBIO presents a Netural setup with a Technical Score of 5.32/10. Key technical indicators highlight an RSI of 46.98 and a MACD of 1.53, with the trend anchored by the 50-Day SMA at 29.27. Traders should monitor key support at 19.60 and resistance at 22.03.
